University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Circulation. 2012 Apr 17;125(15):1858-69. doi: 10.1161/CIRCULATIONAHA.111.064378. Epub 2012 Apr 9.
Elevated serum cholesterol accounts for a considerable proportion of cardiovascular disease worldwide. An understanding of the relationship between country-level economic and health system factors and elevated cholesterol may provide insight for prioritization of cardiovascular prevention programs.
Using hierarchical models, we examined the relationship between elevated total cholesterol (>200 mg/dL) in 53 570 outpatients from 36 countries, and tertiles of several country-level indices: (1) gross national income, (2) total expenditure on health as percentage of gross domestic product, (3) government expenditure on health as percentage of total expenditure on health, (4) out-of-pocket expenditures as percentage of private expenditure on health, and the World Health Organization indices of (5) Health System Achievement and (6) Performance/Efficiency. Overall, 38% of outpatients had total cholesterol >200 mg/dL (>5.18 mmol/L), and 9.3% of the total variability in elevated cholesterol was at the country level; this proportion was higher for patients with (12.1%) versus without (7.4%) history of hyperlipidemia. Among patients with history of hyperlipidemia, countries in the highest tertile of gross national income or World Health Organization Health System Achievement had lower odds of elevated cholesterol than lower tertiles (P<0.001, for both). Countries in the highest tertile of out-of-pocket health expenditures had higher odds of elevated cholesterol than those in the lowest tertile (P<0.001). No significant associations were found for patients without history of hyperlipidemia.
Global variations in the prevalence of elevated cholesterol among patients with history of hyperlipidemia are associated with country-level economic development and health system indices. These results support the need for strengthening efforts toward effective cardiovascular disease prevention and control and may provide insight for health policy setting at the national level.
血清胆固醇升高在全球范围内占心血管疾病的相当大比例。了解国家经济和卫生系统因素与胆固醇升高之间的关系,可以为优先考虑心血管预防计划提供深入了解。
使用层次模型,我们检查了来自 36 个国家的 53570 名门诊患者中升高的总胆固醇(>200mg/dL)与几个国家水平指数的三分位数之间的关系:(1)国民总收入,(2)卫生总支出占国内生产总值的百分比,(3)政府卫生支出占卫生总支出的百分比,(4)自付支出占私人卫生支出的百分比,以及世界卫生组织的(5)卫生系统绩效和(6)绩效/效率指数。总体而言,38%的门诊患者总胆固醇>200mg/dL(>5.18mmol/L),总胆固醇升高的 9.3%可归因于国家层面;有(12.1%)与无(7.4%)高脂血症病史的患者之间这一比例更高。在有高脂血症病史的患者中,国民总收入或世界卫生组织卫生系统绩效较高的国家中,胆固醇升高的可能性低于较低的三分位数(均 P<0.001)。自付健康支出最高三分位的国家比最低三分位的国家胆固醇升高的可能性更高(P<0.001)。对于没有高脂血症病史的患者,未发现显著相关性。
有高脂血症病史的患者中胆固醇升高的全球差异与国家经济发展和卫生系统指数有关。这些结果支持加强有效控制心血管疾病的努力的必要性,并可能为国家层面的卫生政策制定提供深入了解。